PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Pharma-Bio Serv, Inc.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$0.48+0.08 (+20.00%)
Close on Oct 19, 2026
- Market cap
- $11.00M
- P/E (TTM)
- 48.0
- Dividend yield
- –
Pharma-Bio Serv, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Puerto Rico Consulting [Member] | $5.14M | $4.98M | $4.70M | $4.64M | $4.86M | $5.11M | $5.40M | $5.69M | $6.21M | $6.76M | $7.25M | $8.04M | 54.2% | +5.8% |
| United States Consulting [Member] | $2.52M | $2.43M | $2.52M | $2.62M | $2.74M | $2.84M | $2.93M | $3.16M | – | – | – | – | 26.6% | -8.0% |
| Europe Consulting [Member] | $1.81M | $1.68M | $1.59M | $1.73M | $1.56M | $1.69M | $1.23M | $571.18K | $887.28K | $2.00M | $3.36M | $4.26M | 19.1% | +15.8% |
| Other Segment [Member] | – | – | – | – | $18.26K | $3.00K | $44.57K | $85.78K | $85.78K | $83.45K | $48.12K | $6.23K | – | – |
From the segment and revenue-disaggregation notes of Pharma-Bio Serv's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.